1. Home
  2. ARMP vs UNB Comparison

ARMP vs UNB Comparison

Compare ARMP & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • UNB
  • Stock Information
  • Founded
  • ARMP N/A
  • UNB 1891
  • Country
  • ARMP United States
  • UNB United States
  • Employees
  • ARMP N/A
  • UNB N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • UNB Major Banks
  • Sector
  • ARMP Health Care
  • UNB Finance
  • Exchange
  • ARMP Nasdaq
  • UNB Nasdaq
  • Market Cap
  • ARMP 125.7M
  • UNB 117.7M
  • IPO Year
  • ARMP N/A
  • UNB 1998
  • Fundamental
  • Price
  • ARMP $5.73
  • UNB $22.64
  • Analyst Decision
  • ARMP Strong Buy
  • UNB
  • Analyst Count
  • ARMP 1
  • UNB 0
  • Target Price
  • ARMP $9.00
  • UNB N/A
  • AVG Volume (30 Days)
  • ARMP 759.0K
  • UNB 11.0K
  • Earning Date
  • ARMP 11-07-2025
  • UNB 01-16-2026
  • Dividend Yield
  • ARMP N/A
  • UNB 6.20%
  • EPS Growth
  • ARMP N/A
  • UNB N/A
  • EPS
  • ARMP N/A
  • UNB 2.01
  • Revenue
  • ARMP $6,868,000.00
  • UNB $48,950,000.00
  • Revenue This Year
  • ARMP $8.43
  • UNB N/A
  • Revenue Next Year
  • ARMP N/A
  • UNB N/A
  • P/E Ratio
  • ARMP N/A
  • UNB $11.56
  • Revenue Growth
  • ARMP 84.67
  • UNB 2.99
  • 52 Week Low
  • ARMP $0.90
  • UNB $21.79
  • 52 Week High
  • ARMP $16.34
  • UNB $37.70
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 63.43
  • UNB 35.17
  • Support Level
  • ARMP $4.65
  • UNB $22.63
  • Resistance Level
  • ARMP $6.36
  • UNB $25.46
  • Average True Range (ATR)
  • ARMP 1.34
  • UNB 0.60
  • MACD
  • ARMP 0.01
  • UNB -0.08
  • Stochastic Oscillator
  • ARMP 22.25
  • UNB 20.78

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

Share on Social Networks: